US Treasury proposes a rule to crack down on high-tech investments in China, other adversaries
- On Thursday, the Treasury Department proposed rules to restrict American high-tech investments in China, Russia, North Korea, and other "countries of concern" to prevent military advancement.
- Congress passed the Comprehensive Outbound Investment National Security Act in December 2025, expanding bipartisan restrictions first established by President Joe Biden in 2023 through executive order.
- Investments exceeding $50,000 trigger the rules, which ban artificial intelligence termed "superintelligence" due to rapid advances. Treasury Assistant Secretary Chris Pilkerton said measures target "the network, the supply chain, and things like that."
- Treasury excluded Venezuela because Nicolas Maduro's government "no longer exists" following his capture, while rules exempt licensing agreements for U.S. pharmaceutical companies including Pfizer.
- Public comment periods close December 7 before final rules take effect. Russia's inclusion follows President Donald Trump's recent sanction waiver, reflecting tensions between security concerns and diplomatic engagement.
114 Articles
114 Articles
Treasury seeks new restrictions on U.S. security-linked funding in China
The U.S. is expanding restrictions on foreign investment in China, ranging from current curbs on artificial intelligence to a ban on technology related to key Chinese weapon developments, according to a proposed Treasury Department rule. Source: The Washington Times
Beijing condemned on Friday the US proposal to restrict investments in Chinese biotechnology companies, warning that this initiative "is not in anyone's interest," reports AFP, according to Agerpres.
The U.S. Treasury wants expanded restrictions on high-tech investments to these ‘countries of concern’
The U.S. Treasury Department proposed a rule Thursday to crack down on American high-tech investments such as supercomputing and artificial intelligence in China, Russia, North Korea and other “countries of concern.”The U.S. government has been working for years to deny China and other adversaries investments that could help them boost their military power.That program began in 2023 when then-President Joe Biden signed an executive order putting…
US moots curbs on funds to Chinese biotech firms
The administration of US President Donald Trump is seeking to restrict investment in Chinese biotechnology companies, potentially complicating financial ties at a time when US drugmakers are increasingly turning to China for new medicines.The US Department of the Treasury on Thursday proposed adding
Coverage Details
Bias Distribution
- 47% of the sources are Center
Factuality
To view factuality data please Upgrade to Premium
